*Program Evaluation and Research Unit, School of Pharmacy, University of Pittsburgh, Pittsburgh
†Office of Medical Assistance Programs, Pennsylvania Department of Human Services, Harrisburg, PA
‡RTI International, Durham
§Behavioral Health Economics Program, RTI International, Research Triangle Park, NC
∥Department of Family Medicine, Allegheny Health Network, Monroeville
¶Research and Faculty Academic Affairs, Department of Emergency Medicine, Allegheny General Hospital
#Gateway Health Plan, Four Gateway Center
**UPMC For You, University of Pittsburgh Medical Center Health Plan, US Steel Tower, Pittsburgh, PA
Supported by the Substance Abuse and Mental Health Services Administration (SAMHSA) via grant number 5U79T1020263, the Jewish Healthcare Foundation, and the Staunton Farm Foundation. SAMHSA has awarded grants to the University of Pittsburgh, School of Pharmacy where J.L.P. and S.M.K. are employed.
Presented at the following public meetings and conferences: INEBRIA, September 2016, Lausanne, Switzerland; Office of National Drug Control Policy Meeting, Webinar, August 2016; Overdose Task Force 2016, Coordinating Care for Individuals with Substance Use Disorders, June 2016, Pittsburgh, PA; and Healthcare Common Procedure Coding System Meeting, March 2016, Pittsburgh, PA.
J.L.P. is a consultant for the Substance Abuse and Mental Health Services Administration (SAMHSA). The remaining authors declare no conflict of interest.
Reprints: Janice L. Pringle, PhD, Program Evaluation and Research Unit, School of Pharmacy, University of Pittsburgh, 5607 Baum Boulevard, Pittsburgh, PA 15206. E-mail: jlp127@pitt.edu.
